Frontlight ResearchEarly access
Type 1 diabetes trials in Switzerland
4 of 9 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Bern
- Age
- 1 year to 25 years
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - Phase 3CompletedA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Geneva
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - Phase 2/3Not yet taking people in SwitzerlandA Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- Where
- Bern
- Age
- 18 years and over
- People
- 105 worldwide
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07284511 - Phase 3Taking peopleGIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
- Where
- Chêne-Bougeries, Lucerne, Olten
- Age
- 18 years to 65 years
- People
- 42
- Run by
- University of Bern
See details and how to joinNCT06630585